What You Should Know:
– The U.S. Department of Health and Human Services (HHS) today announced a $100M pilot funding opportunity aimed at preventing, testing for, treating, and curing Hepatitis C (HCV) in individuals with…
Continue Reading
Major Consumer Protection Enhancements
CMS is implementing robust safeguards starting in 2026 to prevent unauthorized changes to healthcare coverage within the Federally-facilitated Marketplaces (FFMs). These improvements will significantly enhance consumer experience on HealthCare.gov, making cost…
Alchemy, a company that helps develop and scale in-house pharmacy programs focused on HIV and Hepatitis C (HCV) patient populations, announced it closed $31 million in seed financing led by Andreessen Horowitz (“a16z”) Bio…
Continue Reading
What You Should Know:
– Alchemy, a healthcare company focused on improving access to medications for underserved populations secures $31M in seed funding.
– The investment was led by Andreessen Horowitz (a16z) Bio + Health, with…
Continue Reading
Large language models (LLMs) can potentially transform healthcare, particularly in providing the right information to the right provider at the right time in the hospital workflow. This study investigates the integration of LLMs into…
Continue Reading
By Anuja Vaidya
November 17, 2023 – Telehealth provides an effective strategy for treating opioid use disorder (OUD) patients with hepatitis C virus (HCV), according to a new study.
Conducted by researchers at the University at Buffalo…
Continue Reading
NHS England and Preventx have launched a digital-first, remote testing service for hepatitis C, which will support the NHS’ ambition to eliminate the virus ahead of the World Health Organization (WHO)’s goal of eradicating…
Continue Reading
